Cadre (CDRE) Competitors

Bausch + Lomb (NYSE:BLCO) and Cadre (NYSE:CDRE) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability, media sentiment, dividends and community ranking.

Does the media favor BLCO or CDRE?

In the previous week, Bausch + Lomb had 25 more articles in the media than Cadre. MarketBeat recorded 26 mentions for Bausch + Lomb and 1 mentions for Cadre. Cadre's average media sentiment score of 0.70 beat Bausch + Lomb's score of 0.23 indicating that Cadre is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bausch + Lomb	4 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	5 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cadre	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts recommend BLCO or CDRE?

Bausch + Lomb presently has a consensus target price of $19.83, indicating a potential upside of 25.97%. Cadre has a consensus target price of $39.67, indicating a potential upside of 17.76%. Given Bausch + Lomb's higher possible upside, research analysts clearly believe Bausch + Lomb is more favorable than Cadre.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bausch + Lomb	1 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.31
Cadre	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

Is BLCO or CDRE more profitable?

Cadre has a net margin of 6.34% compared to Bausch + Lomb's net margin of -6.62%. Cadre's return on equity of 12.88% beat Bausch + Lomb's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bausch + Lomb	-6.62%	3.34%	1.66%
Cadre	6.34%	12.88%	6.06%

Does the MarketBeat Community prefer BLCO or CDRE?

Bausch + Lomb received 22 more outperform votes than Cadre when rated by MarketBeat users. However, 55.17% of users gave Cadre an outperform vote while only 42.22% of users gave Bausch + Lomb an outperform vote.

Company	Underperform	Outperform
Bausch + Lomb	Outperform Votes 38 42.22%	Underperform Votes 52 57.78%
Cadre	Outperform Votes 16 55.17%	Underperform Votes 13 44.83%

Do institutionals & insiders have more ownership in BLCO or CDRE?

11.1% of Bausch + Lomb shares are owned by institutional investors. Comparatively, 44.0% of Cadre shares are owned by institutional investors. 0.2% of Bausch + Lomb shares are owned by insiders. Comparatively, 37.0% of Cadre shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Which has more risk & volatility, BLCO or CDRE?

Bausch + Lomb has a beta of 0.46, suggesting that its share price is 54% less volatile than the S&P 500. Comparatively, Cadre has a beta of 1.27, suggesting that its share price is 27% more volatile than the S&P 500.

Which has better earnings and valuation, BLCO or CDRE?

Cadre has lower revenue, but higher earnings than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than Cadre, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bausch + Lomb	$4.79B	1.16	-$260M	-$0.91	-17.30
Cadre	$482.53M	2.83	$38.64M	$0.83	40.58

Summary

Cadre beats Bausch + Lomb on 13 of the 18 factors compared between the two stocks.